Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

BACKGROUND: Platinum-based therapy (PBT) is the standard therapy for recurrent and/or metastatic head and neck cancer (HNC), but the incidence of recurrence remains high. This study evaluates the efficacy and tolerability of capecitabine as palliative monotherapy for recurrent HNC previously treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Trufero, J, Isla, D, Adansa, J C, Irigoyen, A, Hitt, R, Gil-Arnaiz, I, Lambea, J, Lecumberri, M J, Cruz, J J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883700/
https://www.ncbi.nlm.nih.gov/pubmed/20485287
http://dx.doi.org/10.1038/sj.bjc.6605697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883700/
https://www.ncbi.nlm.nih.gov/pubmed/20485287
http://dx.doi.org/10.1038/sj.bjc.6605697

Ejemplares similares